» Articles » PMID: 35812253

Predictors and Time to Recovery from COVID-19 Among Patients Attended at the Treatment Centers in Ekiti State, South West, Nigeria

Overview
Journal Pan Afr Med J
Date 2022 Jul 11
PMID 35812253
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: time to clinical recovery from COVID-19 infection and associated factors has not been explored in Nigeria. This study was conducted to assess the predictors and time to recovery from COVID-19 among patients attended to at the treatment centers in Ekiti State, South West.

Methods: a facility-based retrospective cohort study was conducted between March 2020 to October 2021. Laboratory confirmed COVID-19 positive test result of 586 patients receiving treatment at the treatment centres in Ekiti were included. Data were extracted from COVID-19 intake forms and medical records of patients. Data were analysed using descriptive statistics and survival analysis methods including Cox proportional hazards regression model. Level of significance was set at 5%.

Results: the mean age of the patients was 43.46 (SD 0.74) years. Forty-seven percent (47%) of the patients were aged 25-44 years, fifty-one percent (51%) were males. The median recovery time of COVID-19 patients was 21 days (IQR: 14-23). Being a male-patient (95% CI 20.46-21.54), older age (95% CI 20.14-21.86), not admitted in the hospital (95% CI 22.74-23.26), and associated multiple co-morbidities (95% CI 17.65-28.35) were associated with delayed recovery time. Predictors of recovery time of patients from COVID-19 infection were admission status (aHR: 0.71, 95%CI 0.56-0.88; p=0.002) and symptoms on admission (aHR: 0.81, 95%CI 0.66-0.99; p=0.020).

Conclusion: patients with comorbidities, older and those not admitted were more likely to have a delayed clinical recovery from COVID-19. Knowledge of the predictors might help health professionals in risk stratification and better management of patients with COVID-19.

Citing Articles

Time to recovery of COVID-19 patients and its predictors: a retrospective cohort study in HUCSH, Sidama, Ethiopia.

Anteneh A, Asfaw Z BMC Public Health. 2025; 25(1):74.

PMID: 39773164 PMC: 11707994. DOI: 10.1186/s12889-024-21229-7.


Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population.

Angulo-Aguado M, Carrillo-Martinez J, Contreras-Bravo N, Morel A, Parra-Abaunza K, Usaquen W Sci Rep. 2024; 14(1):8497.

PMID: 38605121 PMC: 11009356. DOI: 10.1038/s41598-024-57982-3.


The German COVID-19 Digital Contact Tracing App: A Socioeconomic Evaluation.

Ellmann S, Maryschok M, Schoffski O, Emmert M Int J Environ Res Public Health. 2022; 19(21).

PMID: 36361198 PMC: 9654962. DOI: 10.3390/ijerph192114318.

References
1.
Wang K, Zhang X, Sun J, Ye J, Wang F, Hua J . Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019. Chest. 2020; 158(5):1876-1884. PMC: 7305751. DOI: 10.1016/j.chest.2020.06.015. View

2.
Workneh Leulseged T, Maru E, Hassen I, Zewde W, Chamiso N, Abebe D . Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study. Pan Afr Med J. 2021; 38:351. PMC: 8308857. DOI: 10.11604/pamj.2021.38.351.28831. View

3.
Bhapkar H, Mahalle P, Dey N, Santosh K . Revisited COVID-19 Mortality and Recovery Rates: Are we Missing Recovery Time Period?. J Med Syst. 2020; 44(12):202. PMC: 7585674. DOI: 10.1007/s10916-020-01668-6. View

4.
Qi L, Yang Y, Jiang D, Tu C, Wan L, Chen X . Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study. Int J Infect Dis. 2020; 96:531-537. PMC: 7231495. DOI: 10.1016/j.ijid.2020.05.045. View

5.
Guan W, Liang W, He J, Zhong N . Cardiovascular comorbidity and its impact on patients with COVID-19. Eur Respir J. 2020; 55(6). PMC: 7236831. DOI: 10.1183/13993003.01227-2020. View